CC BY-NC-ND 4.0 · Sleep Sci 2022; 15(03): 370-373
DOI: 10.5935/1984-0063.20220065
CASE REPORTS

Sleepwalking, sleep-related eating disorder and sleep-related smoking successfully treated with topiramate: a case report

Sana Elham Kazi
1   Interfaith Medical Center, Department of Psychiatry - Brooklyn - New York - United States
,
Jamal Mujaddid M Mohammed
2   University of California Davis, Department of Internal Medicine - Sacramento - California - United States
3   Northern California Veterans Affairs Health Care System, Sleep Medicine - Sacramento - California - United States
,
Carlos H Schenck
4   Minnesota Regional Sleep Disorders Center, Sleep Medicine - Minneapolis - Minnesota - United States
5   University of Minnesota Medical School, MD - Minneapolis - Minnesota - United States
6   Hennepin County Medical Center, Department of Psychiatry - Minneapolis - Minnesota - United States
› Author Affiliations

We describe a 45-year-old married woman with sleepwalking, sleep-related eating disorder, and sleep-related smoking behavior, but without restless legs syndrome. The patient had a history of mild obstructive sleep apnea with an AHI of 12.6/hour with an oxygen saturation nadir of 95%, which resolved after bariatric surgery. Treatment with topiramate 100mg at bedtime controlled all three parasomnias for ten months at the latest follow-up, with relapse occurring whenever topiramate was stopped. To our knowledge, this is the first reported successful treatment of sleep-related smoking. Clinicians are encouraged to inquire about other types of parasomnias, and other sleep disorders such as narcolepsy, in patients presenting with a complaint of one parasomnia.



Publication History

Received: 23 September 2021

Accepted: 07 February 2022

Article published online:
01 December 2023

© 2023. Brazilian Sleep Association. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil

 
  • REFERENCES

  • 1 American Academy of Sleep Medicine (AASM). International Classification of Sleep Disorders. 3rd ed. Darien: AASM; 2014.
  • 2 Provini F, Vetrugno R, Montagna P. Sleep-related smoking syndrome. Sleep Med. 2008 Dec;9(8):903-5. DOI: https://doi.org/10.1016/j. sleep.2007.10.021
  • 3 Provini F, Antelmi E, Vignatelli L, Zaniboni A, Naldi G, Calandra- Buonaura G, et al. Increased prevalence of nocturnal smoking in restless legs syndrome (RLS). Sleep Med. 2010 Feb;11(2):218-20. doi: 10.1016/j. sleep.2009.05.016. Epub 2010 Jan 12. PMID: 20064746.
  • 4 Palaia V, Poli F, Pizza F, Antelmi E, Franceschini C, Moghadam KK, et al. Narcolepsy with cataplexy associated with nocturnal compulsive behaviors: a case-control study. Sleep. 2011 Oct;34(10):1365-71. DOI: https://doi.org/10.5665/SLEEP.1280
  • 5 Pressman MR. Factors that predispose, prime and precipitate NREM parasomnias in adults: clinical and forensic implications. Sleep Med Rev. 2007 Feb;11(1):5-30;discussion:31-3. DOI: https://doi.org/10.1016/j. smrv.2006.06.003
  • 6 Tale S, Kumar A, Saini LK, Meitei SP, Gupta R. Sleepwalking and prolonged partial sleep paralysis in a case of obstructive sleep apnea. Sleep Sci. 2021 Apr/Jun;14(2):186-9.
  • 7 Schenck CH, Milner DM, Hurwitz TD, Bundlie SR, Mahowald MW. A polysomnographic and clinical report on sleep-related injury in 100 adult patients. Am J Psychiatry. 1989 Sep;146(9):1166-73.
  • 8 Howell MJ, Schenck CH, Crow SJ. A review of nighttime eating disorders. Sleep Med Rev. 2009 Feb;13(1):23-34. DOI: https://doi. org/10.1016/j.smrv.2008.07.005
  • 9 Winkelman JW, Wipper B, Purks J, Mei L, Schoerning L. Topiramate reduces nocturnal eating in sleep-related eating disorder. Sleep. 2020 Sep;43(9):zsaa060. DOI: https://doi.org/10.1093/sleep/zsaa060
  • 10 Johnson BA, Roache JD, Ait-Daoud N, Gunderson EW, Haughey HM, Wang XQ, et al. Topiramate’s effects on cocaine-induced subjective mood, craving and preference for money over drug taking. Addict Biol. 2013;18(3):405-16.
  • 11 Nourredine M, Jurek L, Angerville B, Longuet Y, Ternay J, Derveaux A, et al. Use of topiramate in the spectrum of addictive and eating disorders: a systematic review comparing treatment schemes, efficacy, and safety features. CNS Drugs. 2021 Feb;35(2):177-213.
  • 12 Soares C, Fernandes N, Morgado P. A review of pharmacologic treatment for compulsive buying disorder. CNS Drugs. 2016;30(4):281-91.
  • 13 Goslar M, Leibetseder M, Muench HM, Hofmann SG, Laireiter AR. Pharmacological treatments for disordered gambling: a meta-analysis. J Gambl Stud. 2019 Jun;35(2):415-45.
  • 14 Khazaal Y, Zullino DF. Topiramate in the treatment of compulsive sexual behavior: case report. BMC Psychiatry. 2006 May;6:22. DOI: https://doi.org/10.1186/1471-244X-6-22
  • 15 Oulis P, Kokras N, Papadimitriou GN, Masdrakis VG. Bupropioninduced sleepwalking. J Clin Psychopharmacol. 2010 Feb;30(1):83-4. DOI: https://doi.org/10.1097/JCP.0b013e3181c9c8a2
  • 16 Stapleton J, West R, Hajek P, Wheeler J, Vangeli E, Abdi Z, et al. Randomized trial of nicotine replacement therapy (NRT), bupropion and NRT plus bupropion for smoking cessation: effectiveness in clinical practice. Addiction. 2013 Dec;108(12):2193-201. DOI: https:// doi.org/10.1111/add.12304